The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Presynaptic nicotinic ACh receptors
Abstract
Nicotinic ACh (nACh) receptors in the CNS are composed of a diverse array of subunits and have a range of pharmacological properties. However, despite the fact that they are ligand-gated cation channels, their physiological functions have not been determined. This has led to increased interest in presynaptic nACh receptors that act to modulate the release of transmitter from presynaptic terminals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Instead, central cholinergic neurotransmission predominantly changes neuronal excitability, alters presynaptic release of neurotransmitters, and coordinates the firing of groups of neurons (Kawai et al., 2007; Rice and Cragg, 2004; Wonnacott, 1997; Zhang and Sulzer, 2004).”
From Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior (2012) · cites this paper as Wonnacott, 1997
In the citing paper
“In addition, stimulation of nAChRs can increase the release of glutamate, GABA, dopamine (DA), ACh, norepinephrine, and serotonin (McGehee et al., 1995; Wonnacott, 1997) (Figure 1).”
From Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior (2012) · cites this paper as Wonnacott, 1997
Citations
Cites
Séguéla, P., Wadiche, J. I., Dineley‐Miller, K., Dani, J., & Jw, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471
Lev, S., Moreno, H., Martinez, R., Canoll, P., Peles, E., Musacchio, J. M., Plowman, G. D., Rudy, B., & Schlessinger, J. (1995) · Nature · doi:10.1038/376737a0 · Cited by 1,382
Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P., & Role, L. W. (1995) · Science · doi:10.1126/science.7569895 · Cited by 1,070
The Diversity of Neuronal Nicotinic Acetylcholine Receptors
Sargent, P. B. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.002155 · Cited by 1,052
Wada, E., Wada, K., Boulter, J., Deneris, E. S., Heinemann, S., Patrick, J., & Swanson, L. W. (1989) · The Journal of Comparative Neurology · doi:10.1002/cne.902840212 · Cited by 1,044
Physiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate Neurons
McGehee, D. S., & Role, L. W. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.002513 · Cited by 1,022
Hippocampal synaptic transmission enhanced by low concentrations of nicotine
Gray, R. G. F., Rajan, A. S., Radcliffe, K. A., Yakehiro, M., & Dani, J. A. (1996) · Nature · doi:10.1038/383713a0 · Cited by 947
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880
Nicotinic Receptors in the Development and Modulation of CNS Synapses
Role, L. W., & Berg, D. K. (1996) · Neuron · doi:10.1016/s0896-6273(00)80134-8 · Cited by 762
Intercellular communication in the brain: Wiring versus volume transmission
Agnati, L. F., Zoli, M., Strömberg, I., & Fuxé, K. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00308-6 · Cited by 569
Research works printed but not linked: 10
- Yang, 1996, J. Pharmacol. Exp. Ther., 276, 482
- Marks, 1995, J. Pharmacol. Exp. Ther., 274, 833
- Marshall, D. et al. Neuropharmacology (in press)
- Sacaan, 1995, J. Pharmacol. Exp. Ther., 274, 224
- Sacaan, 1996, J. Pharmacol. Exp. Ther., 276, 509
- Papke, 1994, Mol. Pharmacol., 45, 142
- Peng, 1994, Mol. Pharmacol., 46, 523
- Flores, 1992, Mol. Pharmacol., 41, 31
- Cachelin, 1994, Mol. Pharmacol., 46, 1168
- Bowman W.C. (1996) in Neuromuscular Transmission (Fundamentals of Anaesthesia and Acute Medicine) (Booij, L.H.D., ed.), pp. 1–27, BMJ Publishing Group
Cited by
Sorted by citations
Items 601–700 of 1,001
COURT, J. A., Johnson, M., Religa, D., Keverne, J., Kalaria, R. N., Jaros, E., McKeith, I. G., Perry, R., Näslund, J., & Perry, E. K. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00674.x · Cited by 36
Ventral hippocampal NMDA blockade and nicotinic effects on memory function
Levin, E. D., Sledge, D., Baruah, A., & Addy, N. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00183-7 · Cited by 36
Mutations of the neuronal nicotinic acetylcholine receptors and their association with ADNFLE
Itier, V., & Bertrand, D. (2002) · Neurophysiologie Clinique · doi:10.1016/s0987-7053(02)00294-0 · Cited by 36
Soliakov, L. S., & Wonnacott, S. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703873 · Cited by 36
Self-citationMolecular and Antigenic Structure of Nicotinic Acetylcholine Receptors
Lindstrom, J. M., Peng, X.-D., Kuryatov, A., Lee, E. B., Anand, R., Gerzanich, V., WANG, F., Wells, G. B., & NELSON, M. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10910.x · Cited by 36
Neuronal nicotinic acetylcholine receptors are important targets for alcohol reward and dependence
Wu, J., Gao, M., & Taylor, D. H. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.181 · Cited by 35
Modulatory compartments in cortex and local regulation of cholinergic tone
Coppola, J. J., Ward, N. J., Jadi, M. P., & Disney, A. A. (2016) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2016.08.001 · Cited by 35
Thany, S. H., & Tricoire-Leignel, H. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376343 · Cited by 34
Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD
Francis, P. T. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5247-7 · Cited by 36
Cox, B. C., Marritt, A. M., Perry, D. C., & Kellar, K. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05282.x · Cited by 43
Francis, M. M., Vazquez, R. W., Papke, R. L., & Oswald, R. E. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.1.109 · Cited by 35
Neuronal nicotinic acetylcholine receptor modulation by general anesthetics
Flood, P. D., & Role, L. W. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00179-9 · Cited by 35
Soukup, O., Winder, M., Killi, U. K., Wsol, V., Jun, D., Kuca, K., & Tobin, G. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666160607212615 · Cited by 34
Shiraishi, M., Minami, K., Uezono, Y., Yanagihara, N., Shigematsu, A., & Shibuya, I. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704703 · Cited by 34
Kiguchi, N., Kobayashi, Y., Maeda, T., Tominaga, S., Nakamura, J., Fukazawa, Y., Ozaki, M., & Kishioka, S. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.09.001 · Cited by 34
Single‐Channel Analyses of Ethanol Modulation of Neuronal Nicotinic Acetylcholine Receptors
Zuo, Y., Nagata, K., Yeh, J. Z., & Narahashi, T. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000125349.99823.8a · Cited by 34
Feed-forward facilitation of glutamate release by presynaptic GABAA receptors
Jang, I., Ito, Y., & Akaike, N. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.030 · Cited by 36
Nicotinic–serotonergic drug interactions and attentional performance in rats
Rezvani, A. H., Caldwell, D. P., & Levin, E. D. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2060-y · Cited by 34
Narahashi, T. (2000) · Toxicological Sciences · doi:10.1093/toxsci/57.2.193 · Cited by 34
Mogg, A. J., Jones, F. A., Pullar, I. A., Sharples, C. G. V., & Wonnacott, S. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.013 · Cited by 34
Self-citationModulation of ACh receptor currents by arachidonic acid
Nishizaki, T., Matsuoka, T., Nomura, T., & Sumikawa, K. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00091-6 · Cited by 34
Tredway, T. L., Guo, J., & Chiappinelli, V. A. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.81.2.447 · Cited by 34
Reuben, M., Boye, S., & Clarke, P. B. S. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00004-2 · Cited by 33
McLean, S. L., Grayson, B., Marsh, S., Zarroug, S. H. O., Harte, M., & Neill, J. C. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.08.037 · Cited by 33
Dehydroepiandrosterone, its metabolites and ion channels
Hill, M., Dušková, M., & Stárka, L. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.05.006 · Cited by 34
Ghasemi, M., & Niktarash, A. H. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0044 · Cited by 33
Vallés, A. S., & Barrantes, F. J. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.744597 · Cited by 37
Effects of Ethanol on Excitatory and Inhibitory Synaptic Transmission in Rat Cortical Neurons
Moriguchi, S., Zhao, X., Marszalec, W., Yeh, J. Z., & Narahashi, T. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00266.x · Cited by 33
Miniature Transmitter Release: Accident of Nature or Careful Design?
Otsu, Y., & Murphy, T. H. (2003) · Science s STKE · doi:10.1126/stke.2112003pe54 · Cited by 33
Dourado, M., & Sargent, P. B. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.87.6.3117 · Cited by 33
Mefloquine Enhances Nigral γ-Aminobutyric Acid Release via Inhibition of Cholinesterase
Zhou, C., Xiao, C., McArdle, J. J., & Ye, J. H. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101923 · Cited by 33
Channelopathies can cause epilepsy in man
Steinlein, O. K. (2002) · European Journal of Pain · doi:10.1053/eujp.2001.0319 · Cited by 33
Gould, T. J., & Lewis, M. C. (2005) · Learning & Memory · doi:10.1101/lm.89105 · Cited by 33
Jaiswal, S. J., Pilarski, J. Q., Harrison, C. M., & Fregosi, R. F. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3711-12.2013 · Cited by 32
Receptor‐associated proteins and synaptic plasticity
Bruneau, E., Esteban, J. A., & Akaaboune, M. (2008) · The FASEB Journal · doi:10.1096/fj.08-107946 · Cited by 33
Shin, M., & Venton, B. J. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b02114 · Cited by 32
Durnin, L., Sanders, K. M., & Mutafova–Yambolieva, V. N. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12069 · Cited by 32
Cellular events in nicotine addiction
Penton, R. E., & Lester, R. A. J. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.01.001 · Cited by 33
Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine
Panchal, V., Taraschenko, O. D., Maisonneuve, I. M., & Glick, S. D. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.060 · Cited by 32
Mephedrone and Nicotine: Oxidative Stress and Behavioral Interactions in Animal Models
Budzyńska, B., Boguszewska‐Czubara, A., Kruk-Słomka, M., Kurzepa, J., & Biała, G. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1566-5 · Cited by 32
Brown, R. W., Perna, M. K., Schaefer, T. L., & Williams, M. T. (2006) · Synapse · doi:10.1002/syn.20237 · Cited by 32
Modulation of nicotine-induced attentional enhancement in rats by adrenoceptor antagonists
Hahn, B., & Stolerman, I. P. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1969-5 · Cited by 32
Stitzel, J. A., Dobelis, P., Jimenez, M., & Collins, A. C. (2001) · Pharmacogenetics · doi:10.1097/00008571-200106000-00008 · Cited by 32
Comparison of the effects of nicotine and epibatidine on the striatal extracellular dopamine
Janhunen, S. K., & Ahtee, L. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.05.015 · Cited by 32
Effects of dopamine receptor antagonists on nicotine-induced attentional enhancement
Hahn, B., Shoaib, M., & Stolerman, I. P. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200212000-00003 · Cited by 32
Zarrindast, M., Piri, M., Nasehi, M., & Ebrahimi-Ghiri, M. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.11.010 · Cited by 32
Nicotinic Receptors in Sleep-Related Hypermotor Epilepsy: Pathophysiology and Pharmacology
Becchetti, A., Grandi, L. C., Colombo, G., Meneghini, S., & Amadeo, A. (2020) · Brain Sciences · doi:10.3390/brainsci10120907 · Cited by 31
The α5 Nicotinic Acetylcholine Receptor Subunit Differentially Modulates α4β2* and α3β4* Receptors
Scholze, P., & Huck, S. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.607959 · Cited by 33
Kroker, K. S., Rast, G. F., & Rosenbrock, H. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.09.167 · Cited by 31
Marchi, M., Grilli, M., & Pittaluga, A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00089 · Cited by 32
Son, J., & Winzer‐Serhan, U. H. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.046 · Cited by 31
Evidence that α7 nicotinic receptor modulates glutamate release from mouse neocortical gliosomes
Patti, L., Raiteri, L., Grilli, M., Zappettini, S., Bonanno, G., & Marchi, M. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.03.003 · Cited by 31
Markus, R. P., dos Santos, J. M., Zago, W. M., & Renó, L. A. C. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045625 · Cited by 31
Scholze, P., Orr‐Urtreger, A., Changeux, J., McIntosh, J. M., & Huck, S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707236 · Cited by 31
Beer, A., Slotkin, T. A., Seidler, F. J., Aldridge, J. E., & Yanai, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300582 · Cited by 31
Olivera‐Bravo, S., Ivorra, I., & Morales, A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705965 · Cited by 31
Allosteric modulation of neuronal nicotinic acetylcholine receptors
Buisson, B., & Bertrand, D. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(98)80144-7 · Cited by 31
Toward an Early Diagnosis and Treatment of Alzheimer’s Disease
Nordberg, A. K. (2003) · International Psychogeriatrics · doi:10.1017/s1041610203009499 · Cited by 31
Chen, G.-J., Xiong, Z., & Yan, Z. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-3 · Cited by 30
Yao, Y., Xu, Y., Cai, Z., Liu, Q., Ma, Y., Li, A. N., Payne, T. J., & Li, M. D. (2020) · Psychological Medicine · doi:10.1017/s003329172000063x · Cited by 31
Yang, Z., Seneviratne, C., Wang, S., Ma, J. Z., Payne, T. J., Wang, J., & Li, M. D. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.12.007 · Cited by 31
Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine
Nagy-Grócz, G., Zádor, F., Dvorácskó, S., Bohár, Z., Benyhe, S., Tömböly, C., Párdutz, Á., & Vécsei, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081617 · Cited by 30
Sokolova, E., Matteoni, C., & Nistri, A. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706426 · Cited by 30
Sharifzadeh, M. S., Zamanian, A.-R., Gholizadeh, S., Tabrizian, K., Etminani, M., Khalaj, S., Zarrindast, M., & Roghani, A. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.065 · Cited by 30
Shirane, M., & Nakamura, K. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02939-0 · Cited by 30
Stone, J. D., Terry, A. V., Pauly, J. R., Prendergast, M., & Buccafusco, J. J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02689-5 · Cited by 30
Oyaizu, M., & Narahashi, T. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01077-x · Cited by 30
Nicotinic Acetylcholine Receptor-Mediated [3H]Dopamine Release from Hippocampus
Cao, Y., Surowy, C. S., & Puttfarcken, P. S. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076794 · Cited by 30
Barabino, B., Vailati, S., Moretti, M., McIntosh, J. M., Longhi, R., Clementi, F., & Gotti, C. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.6.1410 · Cited by 30
Disterhoft, J. F. (2003) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2003.08.004 · Cited by 30
Presynaptic nicotinic acetylcholine receptors in the myenteric plexus of guinea pig intestine
Schneider, D. A., & Galligan, J. J. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.3.g528 · Cited by 30
Pilarski, J. Q., & Fregosi, R. F. (2009) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2009.07.022 · Cited by 29
Hauser, S. R., Bracken, A. L., Deehan, G. A., Toalston, J. E., Ding, Z., Truitt, W. A., Bell, R. L., McBride, W. J., & Rodd, Z. A. (2013) · Addiction Biology · doi:10.1111/adb.12048 · Cited by 29
Yamazaki, Y., Fujii, S., Jia, Y., & Sumikawa, K. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05160.x · Cited by 29
Hypocretin mechanisms in nicotine addiction: evidence and speculation
Corrigall, W. A. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1588-2 · Cited by 29
Wang, D., Noda, Y., Zhou, Y., Nitta, A., Furukawa, H., & Nabeshima, T. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.026 · Cited by 29
Gastrointestinal hormones in regulation of memory
Mandal, A., Prabhavalkar, K. S., & Bhatt, L. K. (2018) · Peptides · doi:10.1016/j.peptides.2018.02.003 · Cited by 32
Induction of Fos-immunostaining by nicotine and nicotinic receptor antagonists in rat brain
Seppä, T., Salminen, O., Moed, M., & Ahtee, L. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00093-4 · Cited by 29
Neuropharmacology and Linguistic Neuroplasticity
Hughes, J., Jacobs, D. H., & Heilman, K. M. (2000) · Brain and Language · doi:10.1006/brln.1999.2223 · Cited by 29
Domino, E. F., Ni, L., & Zhang, H. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7106 · Cited by 29
New insights into the molecular and genetic mechanisms underlying idiopathic epilepsies
Steinlein, O. K. (1998) · Clinical Genetics · doi:10.1111/j.1399-0004.1998.tb04279.x · Cited by 29
Roth, A. B., Schaffner, W., & Hertel, C. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990801)57:3 · Cited by 81
Nicotinic Acetylcholine Receptors
Colquhoun, D., Shelley, C., Hatton, C., Unwin, N., & Sivilotti, L. G. (2003) · Wiley eBooks · doi:10.1002/0471266949.bmc030 · Cited by 30
Dunant, Y., & Gisiger, V. (2017) · Molecules · doi:10.3390/molecules22081300 · Cited by 28
D’Souza, M. S., Liechti, M. E., Ramirez-Niño, A. M., Kuczenski, R. T., & Markou, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.103 · Cited by 28
Involvement of spinal Met–enkephalin in nicotine-induced antinociception in mice
Kiguchi, N., Maeda, T., Tsuruga, M., Yamamoto, A., Yamamoto, C., Ozaki, M., & Kishioka, S. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.086 · Cited by 28
Kulak, J. M., & Schneider, J. S. (2004) · Brain Research · doi:10.1016/j.brainres.2003.10.062 · Cited by 28
Tobacco and alcohol use during adolescence: Interactive mechanisms in animal models
Abreu‐Villaça, Y., Manhães, A. C., Krahe, T. E., Filgueiras, C. C., & Ribeiro‐Carvalho, A. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.06.113 · Cited by 28
Azami, K., Etminani, M., Tabrizian, K., Salar, F., Belaran, M., Hosseini, A., Hosseini-Sharifabad, A., & Sharifzadeh, M. S. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.041 · Cited by 28
Subunit and region-specific decreases in nicotinic acetylcholine receptor mRNA in the aged rat brain
Ferrari, R., Pedrazzi, P., Algeri, S., Agnati, L. F., & Zoli, M. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00015-9 · Cited by 29
Chick Optic Lobe Contains a Developmentally Regulated α2α5β2 Nicotinic Receptor Subtype
Balestra, B., Vailati, S., Moretti, M., Hanke, W., Clementi, F., & Gotti, C. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.2.300 · Cited by 28
Caldirola, D., Daccò, S., Grassi, M., Citterio, A., Menotti, R., Cavedini, P., Girardi, P., & Perna, G. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07985 · Cited by 27
The HSPG syndecan is a core organizer of cholinergic synapses
Zhou, X., Vachon, C., Cizeron, M., Romatif, O., Bülow, H. E., Jospin, M., & Bessereau, J. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202011144 · Cited by 31
Bacoside A: Role in Cigarette Smoking Induced Changes in Brain
Vani, G., Anbarasi, K., & Shyamaladevi, C. S. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/286137 · Cited by 27
Biała, G., Kruk-Słomka, M., & Jóźwiak, K. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0866-z · Cited by 27
Can nicotine be used medicinally in Parkinson’s disease?
Thiriez, C., Villafane, G., Grapin, F., Fénelon, G., Rémy, P., & Césaro, P. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.27 · Cited by 27
Vincler, M. A., & Eisenach, J. C. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.10.011 · Cited by 27
Drew, A. E., & Werling, L. L. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00500-5 · Cited by 27
Fuenzalida‐Uribe, N., Meza, R. C., Hoffmann, H. A., Varas, R., & Campusano, J. M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12161 · Cited by 27
Nakamura, M., & Jang, I. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.04.057 · Cited by 27
Metadata
- Authors
- Wonnacott, S.
- Affiliations
- University of Bath (GB)
- Corresponding author
- Wonnacott, Susan
- ORCID
- Wonnacott, Susan
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 1997-02
- Volume
- 20
- Issue
- 2
- Pages
- 92-98
- ISSN
- 0166-2236 (ISSN-L)
- OpenAlex
- W2081391428
- Cited by
- 1,308
- References
- 74
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 15 · 2023: 15 · 2022: 31 · 2021: 16 · 2020: 25 · 2019: 17 · 2018: 25 · 2017: 23 · 2016: 26 · 2015: 36 · 2014: 35 · 2013: 37 · 2012: 22
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Neurosciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- presynaptic nicotinic acetylcholine receptors, ligand-gated cation channels, neurotransmitter release modulation, presynaptic terminals, receptor pharmacology
- MeSH terms
- Animals, Brain, Receptors, Nicotinic, Presynaptic Terminals, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review